Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

HHS sued over RFK’s $11B cuts to infectious disease control
The Department of Health and Human Services is refusing to allocate funds meant to support state and local healthcare initiatives, as the money stemmed from now-defunct COVID-19 control efforts. A coalition of municipalities is suing to lift the block.
FDA announces new recall of Abbott heart pump accessories over significant safety risks
The mobile power units of certain HeartMate 3 and HeartMate II LVADs have been experiencing “sudden, unexpected performance issues” such as turning on, off or even restarting with no warning. These issues can potentially be fatal, according to an alert shared by the FDA.
‘Innovative’ pay model eliminates cost uncertainty for breast and lung cancer screening patients
Experts have proposed “episode-based cost sharing” to address financial toxicity for healthcare consumers, according to new research published in JACR.
Rad tech advocates recognized for their work fighting scope creep in 2 states
The American Society of Radiologic Technologists this week gave its 2025 Awards for Advocacy to both Diane Kosenko, with Radiology Associates of Hartford, Conn., and its Minnesota affiliate.
Congressmen propose bill to address patient safety loophole in medical imaging
Reps. Don Davis, Morgan Griffith and Ben Cline recently introduced the Nuclear Medicine Clarification Act of 2025.

The average wait time for an MRI scan exceeds 90 days in some parts of Canada and may extend to 133 days by 2022, according to a new report.

A special enrollment period implemented by the Biden administration saw more than 2.5 million people sign up for health insurance.

For his part, the Sunshine State leader has advocated for letting parents dictate healthcare decisions, rather than school administrators.

Industry watchers labeled the transition as significant, since bringing new devices to market is much cheaper than pharmaceuticals.

Representatives also introduced the Facilitating Innovation Nuclear Diagnostics Act of 2021 in the U.S. House in July.

The Society of Nuclear Medicine & Molecular Imaging says the feds appear to have reconsidered a controversial recent decision.

Speculation that the Department of Justice could get involved first surfaced back in March.

ACR, the American Society of Neuroradiology and others believe the VA's efforts will have implications beyond the massive healthcare system.